Abstract:Fibrous nanomaterials containing silica, titanium oxide, and carbon nanotubes are notoriously known for their undesirable inflammatory responses and associated toxicities that have been extensively studied in the environmental and occupational toxicology fields. Biopersistance and inflammation of "hard" nanofibers prevent their broader biomedical applications. To utilize the structural benefits of fibrous nanomaterials for functionalization with moieties of therapeutic significance while preventing undesirable immune responses, researchers employ natural biopolymers─RNA and DNA─to design "soft" and biodegradable nanomaterials with controlled immunorecognition. Nucleic acid nanofibers have been shown to be safe and efficacious in applications that do not require their delivery into the cells such as the regulation of blood coagulation. Previous studies demonstrated that unlike traditional therapeutic nucleic acids (e.g., CpG DNA oligonucleotides) nucleic acid nanoparticles (NANPs), when used without a carrier, are not internalized by the immune cells and, as such, do not induce undesirable cytokine responses. In contrast, intracellular delivery of NANPs results in cytokine responses that are dependent on the physicochemical properties of these nanomaterials. However, the structure-activity relationship of innate immune responses to intracellularly delivered fibrous NANPs is poorly understood. Herein, we employ the intracellular delivery of model RNA/DNA nanofibers functionalized with G-quadruplex-based DNA aptamers to investigate how their structural properties influence cytokine responses. We demonstrate that nanofibers' scaffolds delivered to the immune cells using lipofectamine induce interferon response via the cGAS-STING signaling pathway activation and that DNA aptamers incorporation shields the fibers from recognition by cGAS and results in a lower interferon response. This structure-activity relationship study expands the current knowledge base to inform future practical applications of intracellularly delivered NANPs as vaccine adjuvants and immunotherapies.

L-Rhamnose-containing Supramolecular Nanofibrils As Potential Immunosuppressive Materials.

Self‐Assembly of Glycolipid Epimers: Their Supramolecular Morphology Control and Immunoactivation Function

De Novo Chemoattractants Form Supramolecular Hydrogels for Immunomodulating Neutrophils in Vivo

A Rapid Self-Assembly Peptide Hydrogel for Recruitment and Activation of Immune Cells

Modular Platform of Carbohydrates-modified Supramolecular Polymers Based on Dendritic Peptide Scaffolds

Self-assembly of Human Galectin-1 Via Dual Supramolecular Interactions and Its Inhibition of T-cell Agglutination and Apoptosis

Hydrogel-to-Nanoparticle Transition with Immune Cell Activation Controlled by Dual Supramolecular Interactions

Immunostimulation of Fibrous Nucleic Acid Nanoparticles Can be Modulated through Aptamer-Based Functional Moieties: Unveiling the Structure-Activity Relationship and Mechanistic Insights

Enhanced Immunostimulatory Activity of a Cytosine-Phosphate-Guanosine Immunomodulator by the Assembly of Polymer DNA Wires and Spheres

Effects of Polysaccharide from Ramulus mori on Immunologic Functions of Normal Mouse

Supramolecular materials constructed from synthetic glycopeptides via aqueous self-assembly and their bioapplications in immunotherapy

Structure, Molecular Conformation, and Immunomodulatory Activity of Four Polysaccharide Fractions from Lignosus Rhinocerotis Sclerotia.

Self‐Assembling Glycopeptide Conjugate As a Versatile Platform for Mimicking Complex Polysaccharides

Reconstituting the immune killing functions and improving the pharmacokinetics of nanobodies by rhamnolipid conjugation

Supramolecular Glyco-Nanoparticles Toward Immunological Applications

Rational design of a polysaccharide-based viral mimicry nanocomplex for potent gene silencing in inflammatory tissues

Multivalent and multifunctional polysaccharide-based particles for controlled receptor recognition

Supramolecular self-assembly of glycosaminoglycan mimetic nanostructures for cell proliferation and 3D cell culture application

A "Nonsolvent Quenching" Strategy for 3D Printing of Polysaccharide Scaffolds with Immunoregulatory Accuracy

Self-Assembled Injectable Peptide Hydrogels Capable of Triggering Antitumor Immune Response

Glyco-Modification of Mucin Hydrogels to Investigate Their Immune Activity